期刊文献+

抗ProGRP_((31-98))单克隆抗体D-D_3的^(131)I标记及其体内生物学分布研究 被引量:6

Study on biodistribution of ^(131)iodine labeled monoclonal antibody D-D_3 against pro-gastrin-releasing peptide_((31-98)) in healthy Kunming mice
下载PDF
导出
摘要 目的探讨抗胃泌素释放肽前体(ProGRP)(31-98)单克隆抗体D-D3的131I标记方法及其在健康昆明小鼠体内的生物学分布规律与特点。方法采用氯胺-T法用131I标记单克隆抗体D-D3,利用纸层析法测定其标记率、放化纯度和稳定性。取健康昆明小鼠50只,随机分为10组,每组5只,自昆明小鼠尾静脉注射131I-D-D31.48 kBq/100μL(4μCi/100μL),各组小鼠分别于注射后5、153、0 min及1、2、4、8、12、244、8 h处死,取血液、心脏、肝脏、脾脏、肺脏、肾脏、胃、小肠、骨骼(右下肢)、肌肉(右下肢)和脑组织,称质量(g)后测放射性计数(cpm),计算各脏器组织的每克组织百分注射剂量率(%ID/g)及药物动力学参数。结果 131I-D-D3标记率为(86.56±3.8)%,比活度为(2.25±0.05)MBq/μg,放化纯度为(99.27±0.6)%,标记物置于37℃水浴箱放置48 h后的放化纯度为(88.38±0.4)%,与鼠血清充分混合后24 h的放化纯度为(64.43±0.7)%1。31I-D-D3在健康昆明小鼠体内代谢过程符合一级血药动力学二室模型,代谢公式为c=50.234e-2.793t+26.128e-0.018t,T1/2α=0.25 h,T1/2β=37.89 h,在体内主要通过肾脏和肝脏代谢,血液清除较快,胃、肠等组织摄取稍多,脑、肌肉、心脏等组织摄取较少。结论 131I-D-D3标记率及放化纯度高,在体内、外有很好的稳定性。 Objective To study the ^131I labeling methods,stability,and biological distribution pattern of D-D3 antibody against pro-gastrin-releasing peptide 31-98(ProGRP(31-98)).MethodsThe radioiodination of D-D3 antibody was performed using the chloramine-T method.The radiochemical purity was determined through thin-layer chromotography.^131I-D-D3 was injected into the healthy Kunming mice via a tail vein,and the %ID/g for various organs was obtained,and then,the biodistribution and pharmacokinetics of ^131I-D-D3 antibody in healthy Kunming mice were studied.ResultsThe ^131I-D-D3 labeling rate was(86.56±3.8)%.The radiochemical purity of ^131I-D-D3 was(99.27±0.6)%.After 48 h incubating in 37 ℃ water bath,the radiochemical purity was(88.38±0.4)%.While being mixed 24 h with healthy human serum,the radiochemical purity was still more than(64.43±0.7)%.The metabolism of ^131I-D-D3 in healthy Kunming mice was consistent with a two-compartment model with first-order absorption,T1/2α and T1/2β was 0.25,37.89 h,respectively.ConclusionThe labeling efficiency and radiochemical purity of ^131I-D-D3 are high and stable.^131I-D-D3 is a promising radioimmunoimaging reagent for small cell lung cancer(SCLC).
出处 《重庆医学》 CAS CSCD 北大核心 2011年第8期752-754,共3页 Chongqing medicine
基金 苏州市科技发展计划应用基础研究(医疗卫生)资助项目(YJS0926)
关键词 碘放射性同位素 胃泌素释放肽前体ProGPP(31-98) 单克隆抗体D-D3 氯胺T法 iodine radioisotopes pro-gastrin-releasing peptide31-98(ProGRP(31-98)) monoclonal antibody chloramine-T method
  • 相关文献

参考文献16

  • 1McDonald TJ,Ghatei MA,Bloom SR,et al.A qualitative comparison of canine plasma gastroenteropancreatic hormone response to bombesin and the porcine gastrin-releasing peptide(GRP)[J].Regul Pept,1981,2(5):293-304.
  • 2Miyake Y,Kodama T,Yamaguchi K,et al.Progastrin-releasing peptide(31-98)is a specific tumor marker in patients with small cell lung carcinoma[J].Cancer Res,1994,54(8):2136-2140.
  • 3Yamaguchi H,Soda H,Kitazaki T,et al.Serum progastrin-releasing peptide levels followed by whole-body positron emission tomography detects early recurrence of small-cell lung cancer[J].Respirology,2007,12(1):137-139.
  • 4Nordlund MS,Fermer C,Nilsson O.et al.Production and Characterization of Monoclonal Antibodies for Immunoassay of the Lung Cancer Marker proGRP[J].Tumour Biol,2007,28(2):100-110.
  • 5Molina R,Augé JM,Bosch X,et al.Usefulness of serum tumor markers,including progastrin-releasing peptide,in patients with lung cancer:correlation with histology[J].Tumour Biol,2009,30(3):121-129.
  • 6Nordlund MS,Warren DJ,Laerdahl JK,et al.Studies on multiple forms of proGRP in serum from small cell lung cancer patients[J].Tumour Biol,2009,30(5-6):265-275.
  • 7Holdenrieder S,Von Pawel J,Dankelmann E,et al.Nucleosomes,ProGRP,NSE,CYFRA 21-1,and CEA in monitoring first-line chemotherapy of small cell lung cancer[J].Clin Cancer Res,2008,14(23):7813-7821.
  • 8Panigone S,Nunn AD.Lutetium-177-labeled gastrin releasing peptide receptor binding analogs:a novel approach to radionuclide therapy[J].Q J Nucl Med Mol Imaging,2006,50(4):310-321.
  • 9Winther B,Paus E,Reubsaet JL.Determination of the small cell lung cancer associated biomarker pro-gastrin-releasing peptide(ProGRP)using LC-MS[J].J Sep Sci,2007,30(2):234-240.
  • 10Satoh H,Kagohashi K,Kurishima K,et al.Comparison of neurone-specific enolase and pro-gastrin releasing peptide in the prognostic evaluation of small cell lung cancer patients[J].Clin Oncol(R Coll Radiol),2006,18(9):720.

二级参考文献38

  • 1Hans-Jürg Monstein,Niclas Grahn,Mikael Truedsson,Bodil Ohisson.Progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA expression in non-tumor tissues of the human gastrointestinal tract[J].World Journal of Gastroenterology,2006,12(16):2574-2578. 被引量:7
  • 2刘黎,李少林.^(131)I-2F7抗体在荷小细胞肺癌裸鼠体内分布及其对肿瘤的生长抑制作用[J].中华核医学杂志,2006,26(6):357-360. 被引量:7
  • 3Maruno K, Yamaguchi K, Abe K, et al. Immunoreactive gastrinreleasing peptide as a specific tumor marker in patiens with small cell lung carcinoma. Cancer Res, 1989, 49: 629-632.
  • 4Uchida K, Kojima A, Morokawa N, et al. Expression of pro-gas trin releasing peptide and gastrin-releasing peptide receptor mRNA transcripts in tumor cells oi patients with small cell lung Cancer. J Cancer Res Clin Oncol, 2002, 128: 633-640.
  • 5umesny C, Patel O, Lachal S, et al. Synthesis, expression and biological activity of the prohormone for gastrin releasing peptide (ProGRP). Endocrinology, 2006, 147 : 502-509.
  • 6Oremek GM, Sapoutzis N. Pro-gastrin-releasing peptide (Pro-GRP), a tumor marker for small cell lung cancer. Anticancer Res, 2003, 23 : 895-898.
  • 7Molina R, Filella X, Auge JM. ProGRP: a new biomarker for small cell lung cancer. Clin Biochem, 2004, 37: 505-511.
  • 8Satoh H, Kagohashi K, Kurishima K, et al. Comparison of neurone-specific enolase and pro-gastrin releasing peptide in the prognostic evaluation of small cell lung cancer patients. Clin Oncol ( R Call Radial), 2006, 18: 720.
  • 9Yamaguehi H, Soda H, Kitazaki T, et al. Serum progastrin-releasing peptide levels followed by whole-body positron emission tomography detects early recurrence of small-cell lung cancer. Respirology, 2007, 12: 137-139.
  • 10Nordlund MS, Fermer C, Nilsson O, et al. Production and characterization of monoclonal antibodies for immunoassay of the lung cancer marker proGRP. Tumour Biol, 2007, 28 : 100-110.

共引文献15

同被引文献27

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部